Integrin-mediated cell adhesion (WP185)
Homo sapiens
Integrins are receptors that mediate attachment between a cell and the tissues surrounding it, which may be other cells or the extracellular matrix (ECM). They also play a role in cell signaling and thereby define cellular shape, mobility, and regulate the cell cycle. Description reference: [[wikipedia:Integrins|Wikipedia]] Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP185 CPTAC Assay Portal]
Authors
Martijn Van Iersel , Thomas Kelder , Kristina Hanspers , Alex Pico , Zahra Roudbari , Martina Summer-Kutmon , Eric Weitz , and Egon WillighagenActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
- Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden (2021).
- Long Term Culture of the A549 Cancer Cell Line Promotes Multilamellar Body Formation and Differentiation towards an Alveolar Type II Pneumocyte Phenotype (2016).
- MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
CPTAC PancCanNetAnnotations
Pathway Ontology
integrin mediated signaling pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
ITGA4 | GeneProduct | ncbigene:3676 | |
CAPN9 | GeneProduct | ncbigene:10753 | CAPN9; calpain 9 (nCL-4) [EC:3.4.22.17 |
ILK | GeneProduct | ncbigene:3611 | ILK; integrin-linked kinase [EC:2.7.1.-] |
PTK2 | GeneProduct | ncbigene:5747 | PTK2; PTK2 protein tyrosine kinase 2 [EC:2.7.1.112 |
ITGB3 | GeneProduct | ncbigene:3690 | |
ITGAE | GeneProduct | ncbigene:3682 | |
SOS1 | GeneProduct | ncbigene:6654 | SOS1; son of sevenless homolog 1 (Drosophila) |
ZYX | GeneProduct | ncbigene:7791 | ZYX; zyxin |
RAP1A | GeneProduct | ncbigene:5906 | RAP1A; RAP1A member of RAS oncogene family |
ITGAM | GeneProduct | ncbigene:3684 | |
CRK | GeneProduct | ncbigene:1398 | CRK; v-crk sarcoma virus CT10 oncogene homolog (avian |
ITGA7 | GeneProduct | ncbigene:3679 | |
MIR34C | GeneProduct | ensembl:ENSG00000207562 | |
ITGB7 | GeneProduct | ncbigene:3695 | |
MYO-P | GeneProduct | ensembl:ENSG00000138347 | |
CAPN5 | GeneProduct | ncbigene:726 | CAPN5; calpain |
ITGAD | GeneProduct | ncbigene:3681 | |
SEPP1 | GeneProduct | ncbigene:6414 | SEPP1; selenoprotein P plasma |
ROCK1 | GeneProduct | ncbigene:6093 | ROCK1; Rho-associated coiled-coil containing protein kinase |
ITGAV | GeneProduct | ncbigene:3685 | |
ITGA3 | GeneProduct | ncbigene:3675 | |
VCL | GeneProduct | ncbigene:7414 | VCL; vinculin |
RAPGEF1 | GeneProduct | ncbigene:2889 | GRF2; guanine nucleotide-releasing factor 2 (specific for crk proto-oncogene |
ITGA2B | GeneProduct | ncbigene:3674 | |
CAPN6 | GeneProduct | ncbigene:827 | CAPN6; calpain 6 [EC:3.4.22.17] |
RAC2 | GeneProduct | ncbigene:5880 | RAC2; ras-related C3 botulinum toxin substrate 2 (rho family small GTP binding protein Rac2) |
PXN | GeneProduct | ncbigene:5829 | PXN; paxillin |
PAK6 | GeneProduct | ncbigene:56924 | PAK6; p21(CDKN1A)-activated kinase |
MAP2K1 | GeneProduct | ncbigene:5604 | MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.1.-] |
BCAR1 | GeneProduct | ncbigene:9564 | BCAR1; breast cancer anti-estrogen resistance 1 |
ITGB4 | GeneProduct | ncbigene:3691 | |
ITGB8 | GeneProduct | ncbigene:3696 | |
PDPK1 | GeneProduct | ncbigene:5170 | PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.1.37] |
CAPN3 | GeneProduct | ncbigene:825 | CAPN3; calpain 3 (p94) [EC:3.4.22.17] |
SRC | GeneProduct | ncbigene:6714 | SRC; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) [EC:2.7.1.112] |
DOCK1 | GeneProduct | ncbigene:1793 | DOCK1; dedicator of cyto-kinesis |
VAV3 | GeneProduct | ncbigene:10451 | VAV3; vav 3 oncogene |
BRAF | GeneProduct | ncbigene:673 | BRAF; v-raf murine sarcoma viral oncogene homolog B1 [EC:2.7.1.-] |
CAV2 | GeneProduct | ncbigene:858 | CAV2; caveolin 2 |
ITGAL | GeneProduct | ncbigene:3683 | |
ARAF | GeneProduct | ncbigene:369 | ARAF1; v-raf murine sarcoma 3611 viral oncogene homolog 1 [EC:2.7.1.-] |
CAPN11 | GeneProduct | ncbigene:11131 | CAPN11; calpain 11 [EC:3.4.22.17] |
CAPN10 | GeneProduct | ncbigene:11132 | CAPN10; calpain 10 [EC:3.4.22.17 |
ITGAX | GeneProduct | ncbigene:3687 | |
ITGA1 | GeneProduct | ncbigene:3672 | |
FYN | GeneProduct | ncbigene:2534 | FYN; FYN oncogene related to SRC FGR YES [EC:2.7.1.112] |
MAPK10 | GeneProduct | ncbigene:5602 | |
CSK | GeneProduct | ncbigene:1445 | CSK; c-src tyrosine kinase [EC:2.7.1.112] |
CAV3 | GeneProduct | ncbigene:859 | CAV3; caveolin 3 |
RHO | GeneProduct | ncbigene:6010 | RHO; rhodopsin (opsin 2 rod pigment) (retinitis pigmentosa 4 autosomal dominant) |
HRAS | GeneProduct | ncbigene:3265 | |
MAPK7 | GeneProduct | ncbigene:5598 | MAPK7; mitogen-activated protein kinase 7 [EC:2.7.1.- |
CAV1 | GeneProduct | ncbigene:857 | CAV1; caveolin 1 caveolae protein 22kD |
ITGB6 | GeneProduct | ncbigene:3694 | |
MAPK6 | GeneProduct | ncbigene:5597 | MAPK6; mitogen-activated protein kinase 6 [EC:2.7.1.-] |
SHC1 | GeneProduct | ncbigene:6464 | SHC1; SHC (Src homology 2 domain containing) transforming protein 1 |
ITGB1 | GeneProduct | ncbigene:3688 | |
CAPN2 | GeneProduct | ncbigene:824 | CAPN2; calpain 2 (m/II) large subunit [EC:3.4.22.17] |
AKT3 | GeneProduct | ncbigene:10000 | AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B gamma) [EC:2.7.1.-] |
MAP2K2 | GeneProduct | ncbigene:5605 | MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.1.-] |
PIK3R2 | GeneProduct | ncbigene:5296 | PIK3R2; phosphoinositide-3-kinase regulatory subunit polypeptide 2 (p85 beta) |
ITGA9 | GeneProduct | ncbigene:3680 | |
TNS1 | GeneProduct | ncbigene:7145 | TNS; tensi |
CAPN7 | GeneProduct | ncbigene:23473 | CAPN7; calpain 7 [EC:3.4.22.17 |
ITGA5 | GeneProduct | ncbigene:3678 | |
ITGA10 | GeneProduct | ncbigene:8515 | |
RAF1 | GeneProduct | ncbigene:5894 | RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 [EC:2.7.1.-] |
VAV2 | GeneProduct | ncbigene:7410 | VAV2; vav 2 oncogene |
CDC42 | GeneProduct | ncbigene:998 | CDC42; cell division cycle 42 (GTP binding protein 25kD) |
MAP2K5 | GeneProduct | ncbigene:5607 | MAP2K5; mitogen-activated protein kinase kinase 5 [EC:2.7.1.-] |
CAPNS1 | GeneProduct | ncbigene:826 | CAPNS1; calpain small subunit 1 [EC:3.4.22.17] |
ITGB2 | GeneProduct | ncbigene:3689 | |
PAK2 | GeneProduct | ncbigene:5062 | PAK2; p21 (CDKN1A)-activated kinase 2 [EC:2.7.1.-] |
MAP2K3 | GeneProduct | ncbigene:5606 | MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.1.-] |
MAPK1 | GeneProduct | ncbigene:5594 | MAPK1; mitogen-activated protein kinase 1 [EC:2.7.1.-] |
SORBS1 | GeneProduct | ncbigene:10580 | SH3D5; SH3-domain protein 5 (ponsin |
RAP1B | GeneProduct | ncbigene:5908 | RAP1B; RAP1B member of RAS oncogene family |
MAP2K6 | GeneProduct | ncbigene:5608 | MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.1.- |
PAK3 | GeneProduct | ncbigene:5063 | PAK3; p21 (CDKN1A)-activated kinase 3 [EC:2.7.1.-] |
ITGA2 | GeneProduct | ncbigene:3673 | |
AKT2 | GeneProduct | ncbigene:208 | AKT2; v-akt murine thymoma viral oncogene homolog 2 [EC:2.7.1.-] |
CAPN1 | GeneProduct | ncbigene:823 | CAPN1; calpain 1 (mu/I) large subunit [EC:3.4.22.17] |
RAC1 | GeneProduct | ncbigene:5879 | RAC1; ras-related C3 botulinum toxin substrate 1 (rho family small GTP binding protein Rac1) |
ROCK2 | GeneProduct | ncbigene:9475 | ROCK2; Rho-associated coiled-coil containing protein kinase |
GIT2 | GeneProduct | ncbigene:9815 | GIT2; G protein-coupled receptor kinase-interactor 2 |
VASP | GeneProduct | ncbigene:7408 | VASP; vasodilator-stimulated phosphoprotein |
ITGA6 | GeneProduct | ncbigene:3655 | |
PAK1 | GeneProduct | ncbigene:5058 | PAK1; p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog yeast) [EC:2.7.1.-] |
AKT1 | GeneProduct | ncbigene:207 | AKT1; v-akt murine thymoma viral oncogene homolog 1 [EC:2.7.1.-] |
GRB2 | GeneProduct | ncbigene:2885 | GRB2; growth factor receptor-bound protein 2 |
ITGB5 | GeneProduct | ncbigene:3693 | |
ITGA8 | GeneProduct | ncbigene:8516 | |
ITGA11 | GeneProduct | ncbigene:22801 | |
ARHGEF7 | GeneProduct | ncbigene:8874 | ARHGEF7; Rho guanine nucleotide exchange factor (GEF) 7 |
MYLK2 | GeneProduct | ncbigene:85366 | MYLK2; myosin light chain kinase 2 skeletal muscle [EC:2.7.1.117 |
PAK4 | GeneProduct | ncbigene:10298 | PAK4; p21(CDKN1A)-activated kinase 4 [EC:2.7.1.-] |
MAPK4 | GeneProduct | ncbigene:5596 | MAPK4; mitogen-activated protein kinase 4 [EC:2.7.1.-] |
MAPK12 | GeneProduct | ncbigene:6300 | MAPK12; mitogen-activated protein kinase 12 [EC:2.7.1.-] |
RAC3 | GeneProduct | ncbigene:5881 | RAC3; ras-related C3 botulinum toxin substrate 3 (rho family small GTP binding protein Rac3) |
TLN1 | GeneProduct | ncbigene:7094 | TLN1; talin 1 |
SHC3 | GeneProduct | ncbigene:53358 | SHC3; neuronal Sh |
References
- Assembly and signaling of adhesion complexes. Sepulveda JL, Gkretsi V, Wu C. Curr Top Dev Biol. 2005;68:183–225. PubMed Europe PMC Scholia
- The miR-34 family in cancer and apoptosis. Hermeking H. Cell Death Differ. 2010 Feb;17(2):193–9. PubMed Europe PMC Scholia